Combination bupropion SR and varenicline for smoking cessation: a systematic review

Combination Treatment With Varenicline and Bupropion in an Adaptive Smoking Cessation Paradigm

(2014) Jed E. Rose et al.   AMERICAN JOURNAL OF PSYCHIATRY

Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers

(2014) Jon O. Ebbert et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Brain Nicotinic Acetylcholine Receptor Availability and Response to Smoking Cessation Treatment

(2014) Arthur L. Brody et al.   JAMA Psychiatry

Sex Differences in Availability of β2*-Nicotinic Acetylcholine Receptors in Recently Abstinent Tobacco Smokers

(2012) Kelly P. Cosgrove   ARCHIVES OF GENERAL PSYCHIATRY

Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers

(2012) Amira K. Brown et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting

(2012) Jaqueline S. Issa et al.   NICOTINE & TOBACCO RESEARCH

Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats

(2012) Cleo L. Crunelle et al.   NUCLEAR MEDICINE AND BIOLOGY

Varenicline and bupropion sustained-release combination therapy for smoking cessation

(2009) Jon O. Ebbert et al.   NICOTINE & TOBACCO RESEARCH